Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2

O WarburgOn the origin of cancer cellsScience123309314195610.1126/science.123.3191.30913298683

S MazurekCB BoschekF HugoPyruvate kinase type M2 and its role in tumor growth and spreadingSemin Cancer Biol15300308200510.1016/j.semcancer.2005.04.00915908230

D AnastasiouG PoulogiannisJM AsaraInhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responsesScience33412781283201110.1126/science.121148522052977

MS GoldbergPA SharpPyruvate kinase M2-specific siRNA induces apoptosis and tumor regressionJ Exp MedJan232012(Epub ahead of print)10.1084/jem.20111487

W YangY XiaH JiNuclear PKM2 regulates beta-catenin transactivation upon EGFR activationNature480118122201110.1038/nature1059822056988

HR ChristofkMG Vander HeidenMH HarrisThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growthNature452230233200810.1038/nature0673418337823

HR ChristofkMG Vander HeidenN WuPyruvate kinase M2 is a phosphotyrosine-binding proteinNature452181186200810.1038/nature0666718337815

B AltenbergKO GreulichGenes of glycolysis are ubiquitously overexpressed in 24 cancer classesGenomics8410141020200410.1016/j.ygeno.2004.08.01015533718

T SaekiK UedaY TanigawaraHuman P-glycoprotein transports cyclosporin A and FK506J Biol Chem2686077608019937681059

B TanD Piwnica-WormsL RatnerMultidrug resistance transporters and modulationCurr Opin Oncol12450458200010.1097/00001622-200009000-0001110975553

G EnglundP HallbergP ArturssonAssociation between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoringBMC Med28200410.1186/1741-7015-2-815061868

J Carcel-TrullolsF Torres-MolinaA AraicoEffect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposideCancer Chemother Pharmacol54153160200415114410

CQ XiaN LiuGT MiwaInteractions of cyclosporin A with breast cancer resistance proteinDrug Metab Dispos35576582200717220244

P BerthonG PancinoP de CremouxCharacterization of normal breast epithelial cells in primary cultures: differentiation and growth factor receptors studiesIn Vitro Cell Dev Biol28A7167241992

QQ WangH LiT OliverIntegrin beta 1 regulates phagosome maturation in macrophages through Rac expressionJ Immunol18024192428200818250451

Y LiuQ ChenY SongMicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulationFEBS Lett58519631968201110.1016/j.febslet.2011.05.02921609717

JD DombrauckasBD SantarsieroAD MesecarStructural basis for tumor pyruvate kinase M2 allosteric regulation and catalysisBiochemistry4494179429200515996096

KJ LivakTD SchmittgenAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) methodMethods25402408200111846609

EL LarsonAE AielloC Gomez-DuarteBioluminescence ATP monitoring as a surrogate marker for microbial load on hands and surfaces in the homeFood Microbiol20735739200310.1016/S0740-0020(03)00041-8

A IshaqueM Al-RubeaiUse of intracellular pH and annexin-V flow cytometric assays to monitor apoptosis and its suppression by bcl-2 over-expression in hybridoma cell cultureJ Immunol Methods221435719989894897

M LeistB SingleAF CastoldiIntracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosisJ Exp Med18514811486199710.1084/jem.185.8.14819126928

K GarberEnergy deregulation: licensing tumors to growScience31211581159200610.1126/science.312.5777.115816728625

K TaniMC YoshidaH SatohHuman M2-type pyruvate kinase: cDNA cloning, chromosomal assignment and expression in hepatomaGene7350951619882854097

K YamadaT NoguchiRegulation of pyruvate kinase M gene expressionBiochem Biophys Res Commun256257262199910.1006/bbrc.1999.022810079172

R LiJ LiuH XueDiagnostic value of fecal tumor M2-pyruvate kinase for CRC screening: A systematic review and meta-analysisInt J CancerJan192012(Epub ahead of print)10.1002/ijc.27442.

J SchneiderHG VelcovskyH MorrComparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancerAnticancer Res2050535058200011326667

J SchneiderG SchulzeComparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancerAnticancer Res2350895093200314981971

M BuchholzA SchatzM WagnerOverexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathwayEMBO J2537143724200616874304

T MasuoS OkamuraY ZhangCyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigenCancer Lett2856672200910.1016/j.canlet.2009.05.001

JO WoollRH FriesenMA WhiteStructural and functional linkages between subunit interfaces in mammalian pyruvate kinaseJ Mol Biol312525540200110.1006/jmbi.2001.497811563914

A GallimoreA GodkinRegulatory T cells and tumour immunity - observations in mice and menImmunology123157163200810.1111/j.1365-2567.2007.02748.x18067556

TJ CurielG CoukosL ZouSpecific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNat Med10942949200410.1038/nm109315322536

Y WuM BordeV HeissmeyerFOXP3 controls regulatory T cell function through cooperation with NFATCell126375387200610.1016/j.cell.2006.05.04216873067